Renaissance Technologies’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81K Buy
40,500
+15,700
+63% +$31.4K ﹤0.01% 3332
2025
Q1
$62K Sell
24,800
-58,900
-70% -$147K ﹤0.01% 3267
2024
Q4
$247K Sell
83,700
-106,900
-56% -$315K ﹤0.01% 3102
2024
Q3
$574K Buy
190,600
+125,700
+194% +$378K ﹤0.01% 2726
2024
Q2
$226K Sell
64,900
-44,900
-41% -$156K ﹤0.01% 3006
2024
Q1
$580K Buy
+109,800
New +$580K ﹤0.01% 2801
2023
Q1
Sell
-3,493
Closed -$11K 4440
2022
Q4
$11K Sell
3,493
-121,919
-97% -$384K ﹤0.01% 4032
2022
Q3
$572K Buy
125,412
+97,725
+353% +$446K ﹤0.01% 2848
2022
Q2
$731K Sell
27,687
-11,596
-30% -$306K ﹤0.01% 2909
2022
Q1
$1.46M Buy
+39,283
New +$1.46M ﹤0.01% 2455
2021
Q3
Sell
-3,421
Closed -$323K 3880
2021
Q2
$323K Buy
+3,421
New +$323K ﹤0.01% 3123
2021
Q1
Sell
-27,833
Closed -$1.62M 3748
2020
Q4
$1.62M Buy
27,833
+23,700
+573% +$1.38M ﹤0.01% 2251
2020
Q3
$86K Buy
4,133
+3,735
+938% +$77.7K ﹤0.01% 3232
2020
Q2
$6K Buy
+398
New +$6K ﹤0.01% 3384